Search results

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.

A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.

Strategic partnership with the University of Sydney expanded to continue a long history of research collaboration.

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

With enhanced submicron spatial resolution, speed and contrast, the Micro-Computed Tomography beamline opens a window on the micron-scale 3D structure of a wide range of samples relevant to many areas of science including life sciences, materials engineering, anthropology, palaeontology and geology. MCT will be able to undertake high-speed and high-throughput studies, as well as provide a range of phase-contrast imaging modalities.

Research undertaken to understand ancient record of algal blooms

Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.

ANSTO is taking its innovative ANSTO Synroc® and CORIS360® technologies to the world stage at the Waste Management Symposia 2024 in Phoenix, Arizona USA this week (10 – 14 March 2024). Joining over 45 other countries and around 3,000 attendees, an Australian Government contingent comprising of ANSTO and the Australian Radioactive Waste Agency is in attendance to showcase Australia’s extensive radioactive waste management capabilities.

ANSTO works in partnerships and collaborative ventures with national and international organisations. Partner with ANSTO.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

Guide to successful proposals and experiments at the Powder Diffraction beamline.

Update on Nuclear medicine production at ANSTO.

Dr Inna Karatchevtseva, who collaborates with DMTC, was among those identified by The Australian in its Research magazine as a national leader in her field of ceramic engineering